Your browser doesn't support javascript.
loading
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma.
Fraser, G; Cramer, P; Demirkan, F; Silva, R Santucci; Grosicki, S; Pristupa, A; Janssens, A; Mayer, J; Bartlett, N L; Dilhuydy, M-S; Pylypenko, H; Loscertales, J; Avigdor, A; Rule, S; Villa, D; Samoilova, O; Panagiotidis, P; Goy, A; Pavlovsky, M A; Karlsson, C; Hallek, M; Mahler, M; Salman, M; Sun, S; Phelps, C; Balasubramanian, S; Howes, A; Chanan-Khan, A.
Affiliation
  • Fraser G; Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada. fraserg@HHSC.CA.
  • Cramer P; Department of Internal Medicine, Center of Integrated Oncology and German CLL Study Group, University of Cologne, Cologne, Germany.
  • Demirkan F; Division of Hematology, Dokuz Eylul University, Izmir, Turkey.
  • Silva RS; IEP São Lucas/Hemomed Oncologia e Hematologia, São Paulo, Brazil.
  • Grosicki S; Department of Cancer Prevention, Faculty of Public Health, Silesian Medical University, Katowice, Poland.
  • Pristupa A; Regional Clinical Hospital, Ryazan, Russia.
  • Janssens A; Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Mayer J; Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital Brno, Jihlavska, Brno, Czech Republic.
  • Bartlett NL; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.
  • Dilhuydy MS; Hôpital Haut-Lévêque, Pessac, Bordeaux, France.
  • Pylypenko H; Department of Hematology, Cherkassy Regional Oncological Center, Cherkassy, Ukraine.
  • Loscertales J; Hematology Department, Hospital Universitario La Princesa, IIS-IP, Madrid, Spain.
  • Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, University of Tel-Aviv, Tel-Aviv, Israel.
  • Rule S; Department of Haematology, Plymouth University Medical School, Plymouth, UK.
  • Villa D; Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Samoilova O; Nizhny Novogorod Regional Clinical Hospital, Nizhny Novogorod, Russia.
  • Panagiotidis P; 1st Department of Propedeutic Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Goy A; John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ, USA.
  • Pavlovsky MA; Department of Hematology, Fundaleu, Buenos Aires, Argentina.
  • Karlsson C; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Hallek M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Mahler M; Department I of Internal Medicine, University of Cologne, Cologne, Germany.
  • Salman M; Janssen Research & Development, Raritan, NJ, USA.
  • Sun S; Janssen Research & Development, Raritan, NJ, USA.
  • Phelps C; Janssen Research & Development, Raritan, NJ, USA.
  • Balasubramanian S; Janssen Research & Development, Raritan, NJ, USA.
  • Howes A; Janssen Research & Development, Spring House, PA, USA.
  • Chanan-Khan A; Janssen Research & Development, High Wycombe, UK.
Leukemia ; 33(4): 969-980, 2019 04.
Article in En | MEDLINE | ID: mdl-30315239

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Canadá Country of publication: Reino Unido